Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) complicated with sarcopenia is associated with an increased risk of mortality and poses a substantial health burden worldwide. Shenling Baizhu San (SLBZS) shows efficacy in this comorbidity, but how it exerts this effect remains unclear.
Get in touch with yA
Contact yA, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack